Currently out of the existing stock ratings of Alexander Nowak, 89 are a BUY (83.96%), 15 are a HOLD (14.15%), 2 are a SELL (1.89%).

Alexander Nowak

Work Performance Price Targets & Ratings Chart

Analyst Alexander Nowak, currently employed at CRAIG HALLUM, carries an average stock price target met ratio of 45.56% that have a potential upside of 53.25% achieved within 156 days.

Alexander Nowak’s has documented 232 price targets and ratings displayed on 17 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on NTRA, Natera at 13-Nov-2024.

Wall Street Analyst Alexander Nowak

Analyst best performing recommendations are on CDNA (CAREDX).
The best stock recommendation documented was for CDNA (CAREDX) at 5/1/2024. The price target of $15 was fulfilled within 13 days with a profit of $5.82 (63.4%) receiving and performance score of 48.77.

Average potential price target upside

of $77.75 (76.24%) on SIEN (SIENTRA).
of $21.91 (48.92%) on TNDM (TANDEM DIABETES CARE).
of $17.42 (24.8%) on EXAS (EXACT SCIENCES).

CDNA Caredx CELC Celcuity LLC EXAS EXACT Sciences INFU InfuSystems Holdings NEO NeoGenomics NTRA Natera QDEL Quidel SDC SmileDirectClub TECH Bio-Techne Corp TNDM Tandem Diabetes Care DRIO DarioHealth Corp HTGM HTG Molecular Diagnostics SIEN Sientra DMAC DiaMedica Therapeutics BVS Bioventus ALIM Alimera Sciences CVRX CVRx

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Sung Ji Nam (BTIG)